Nalaganje...
Sorafenib: Where Do We Go from Here?
The approval of sorafenib as the first effective drug for the treatment of hepatocellular carcinoma (HCC) represents a milestone in the treatment of this disease. A better understanding of HCC pathogenesis has led to the development of several novel targeted treatments. HCC is treated in a uniquely...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3605708/ https://ncbi.nlm.nih.gov/pubmed/20578152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.23633 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|